Deals coverage from Reuters.
London-listed drugmaker Shire Plc and Japan's Takeda Pharmaceutical Co Ltd plan to announce a preliminary deal on Wednesday, after the latter sweetened its $62 billion acquisition offer, people familiar with the matter said.
Sinclair Broadcast Group Inc <SBGI.O> on Tuesday said it will sell 23 television stations to several companies after completing its $3.9 billion acquisition of Tribune Media Co <TRCO.N>.
Japan's Softbank Group and Alphabet Inc's venture capital fund CapitalG are among investors pouring $1.9 billion into a truck hailing service platform Manbang, the Chinese company said in a statement on Tuesday.
A unit of debt-laden Chinese conglomerate HNA Group [HNAIR.UL] is seeking to raise as much as $1.5 billion by the end of this year in an investment fund that will serve as the group's primary vehicle for global acquisitions, a document reviewed by Reuters showed.
Britain's business minister said there were no national security grounds to intervene in turnaround specialist Melrose's <MRON.L> takeover of UK engineering company GKN <GKN.L>, giving the deal the green light from government.
U.S. supermarket operator Supervalu Inc <SVU.N> said on Tuesday it would sell eight of its distribution centers to an undisclosed buyer for about $483 million.
Buyout firm Leonard Green & Partners LP has agreed to acquire SRS Distribution Inc, a U.S. private equity-owned wholesale distributor of building products, for more than $3 billion, including debt, according to people familiar with the matter.
(LPC) - U.S. engineering firm McDermott’s US$2.26bn term loan fell in the secondary loan market on Tuesday after a US$2bn unsolicited bid from offshore oil services firm Subsea 7 threatened to break up McDermott’s agreed bid for onshore engineering firm Chicago Bridge & Iron (CB&I).
Britain's Learning Technologies Group Plc <LTGL.L> (LTG) said on Tuesday it would buy privately held talent management firm PeopleFluent Holdings Corp for $150 million to expand its presence in the United States.
Japan's Takeda Pharmaceutical <4502.T> has sweetened its $62 billion bid for Shire <SHP.L> as it races to agree terms with the drugmaker before a deadline to strike a deal expires on Wednesday.
Radiant Life Care Private Ltd revised its offer for India's Fortis Healthcare Ltd <FOHE.NS> on Tuesday, proposing to buy one of its hospitals in Mumbai immediately, as a five-way takeover battle for the hospital chain intensifies.
French payments company Worldline <WLN.PA> said on Tuesday it would remain "very active" in seeking M&A opportunities as it aims to become European industry leader, but did not name any potential targets.
A joint venture between Dior-owner LVMH <LVMH.PA> and Italy's Marcolin could triple its production of glasses over time as its portfolio of brands expands.
U.S. financial software firm SS&C Technologies <SSNC.O> has ruled out a counter-bid for Britain's Fidessa <FDSA.L>, which has agreed a 1.5 billion pound ($2.1 billion) takeover by Ion.
Shire <SHP.L> on Tuesday said discussions are ongoing with Takeda Pharmaceutical <4502.T> about the Japanese firm's bid for its Dublin-based rival ahead of a deadline to strike a deal on Wednesday. [L8N1S14PR]
Libstar Holdings <IPO-LBRJ.J> on Tuesday priced its initial public offering in a range of 12.50 rand and 16 rand, valuing the South African maker of sweets and gluten-free buns at 8.5 billion rand ($691.9 million) or more.
Canada's Centerra Gold <CG.TO> said on Tuesday it had received an unsolicited bid for its Kumtor gold mine in Kyrgyzstan from Chaarat Gold Holdings (CGH) <CGH.L> but that it had informed the London-listed company that it was not interested in the offer.
Metals group Liberty House will invest $1 billion to grow its business in India within the next three years, its chief executive said on Tuesday.
Brazil's Raizen Combustiveis SA agreed to buy downstream assets in Argentina from Royal Dutch Shell PLC <RDSa.L> for $950 million, according to a securities filing on Tuesday.
AstraZeneca <AZN.L> is paying up to $45 million to increase its stake in Circassia <CIRCI.L>, backing a company seeking to bounce back from the failure of its allergy drugs by switching all of its focus to respiratory medicines.